| Bioactivity | Asaretoclax is a potent B-cell lymphoma 2 (Bcl-2) inhibitor. Asaretoclax has the potential for the research of cancer[1]. |
| CAS | 2363074-01-3 |
| Formula | C47H57F2N7O7S |
| Molar Mass | 902.06 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. WHO Drug Information. Volume 38, No. 2. |